Publication | Closed Access

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach

Breast OncologyHigh-risk Breast CancerMedicineCancer ManagementPractical ApproachBreast CancerCell BiologyCancer TreatmentMetronomic ChemotherapyOncologyCell TransplantationTumor MicroenvironmentHigh-dose Carboplatin